CIK 0001621227 · Non-accelerated filer<br>Smaller reporting company
Adaptimmune Therapeutics PLC
Sign in to watch- Ticker
- ADAPY
- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- United Kingdom
- Entity type
- operating
- Phone
- 44 1235 430000
- Business address
- 60 JUBILEE AVENUE, MILTON PARK, ABINGDON, OXFORDSHIRE, United Kingdom
- Former names
- Adaptimmune Ltd
- 4 Derivatives Options or other derivatives
- 8-K Event Other events
- UPLOAD Other SEC-generated Letter
- 4 Open-market buy Director bought 47,280 shares at $0.84 ($39,715)
- 8-K Event Executive or director change · Regulation FD disclosure
- CORRESP Other Correspondence Between Filers and SEC Staff
- UPLOAD Other SEC-generated Letter
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 8-K Event Other events
- CORRESP Other Correspondence Between Filers and SEC Staff
- SC 13G/A Stake Amended Statement of Ownership
- SC 13D/A Stake Beneficial Ownership Report
- CORRESP Other Correspondence Between Filers and SEC Staff
- 4 Open-market sale Chief Technology Officer sold 25,000 shares at $13.79 ($344,750)
- UPLOAD Other SEC-generated Letter
- SC 13D Stake Beneficial Ownership Report
- 4 Open-market buy 10% owner bought 15,000,000 shares at $1.67 ($25,000,500)
- 4 Open-market buy 10% owner bought 15,000,000 shares at $1.67 ($25,000,500)
- 4 Open-market buy 10% owner bought 15,000,000 shares at $1.67 ($25,000,500)
Page 25 of 41 · 808 filings